The "Healthcare Contract Research Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.
The global healthcare contract research organization (CRO) market is projected to expand significantly from USD 55.84 billion in 2024 to USD 105.73 billion by 2033, at a CAGR of 7.42%. This growth is propelled by increased investments in drug development, an upsurge in R&D activities, expanding regulatory requirements, the globalization of clinical trials, and escalating trial complexity.
The pressure on drug developers for clinical data management and stringent safety standards increases the reliance on CROs, boosting the demand for these organizations. Additionally, outsourcing drug and device production by pharmaceutical and medical device companies has heightened clinical trials, propelling engagement, especially in developed countries.
The growing burden of non-communicable diseases (NCDs) and an aging population further propel market growth. The CDC reported in October 2024 that over 90% of adults aged 65+ suffer from at least one chronic health condition, intensifying the complexity of clinical trials. Specialized protocols, longer durations, and advanced data management are now essential. Increased life expectancy leads to more age-related diseases, necessitating effective chronic disease management coupled with burgeoning digital technologies transforming drug development. Mobile and wearable devices, artificial intelligence, cloud technology, and associated platforms enhance data accuracy, offering innovative trial designs, improved patient experience, and established study endpoints.
Global clinical trial expansion requires navigating diverse regulatory landscapes. The rising stringency of bodies like the FDA and EMA mandates robust compliance systems. CROs provide regulatory expertise and standardized processes, ensuring trials adhere to global standards. They support documentation and ethics submissions, helping sponsors accelerate market access by mitigating compliance risks. As regulatory complexities increase, CRO dependence grows, sustaining market growth.
Global Healthcare Contract Research Organization Market Report Segmentation
This report provides revenue growth forecasts at global, regional, and country levels, analyzing industry trends from 2021 to 2033. The global healthcare CRO market is segmented based on type, service, therapeutic area, molecule, and region:
-
Type Outlook (Revenue, USD Million, 2021-2033):
- Drug Discovery
- Pre-Clinical
- Clinical
-
Service Outlook (Revenue, USD Million, 2021-2033):
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient and Site Recruitment
- Technology
-
Therapeutic Area Outlook (Revenue, USD Million, 2021-2033):
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
-
Molecule Outlook (Revenue, USD Million, 2021-2033):
- Pharmaceutical
- Medical Device
-
Regional Outlook (Revenue, USD Million, 2021-2033):
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain insights into the market across regions and segments.
- Competitive Landscape: Explore the presence of key market players.
- Future Trends: Learn about drivers shaping the market's future.
- Actionable Recommendations: Utilize insights to discover revenue opportunities and strategic guidance.
Report Deliverables
- Effective market intelligence for decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analysis.
- Segment and regional revenue forecasts.
- Competition strategy and market share analysis.
- Listings of product innovations.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024-2033 |
| Estimated Market Value (USD) in 2024 | $55.84 Billion |
| Forecasted Market Value (USD) by 2033 | $105.73 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
The companies profiled in this Healthcare Contract Research Organization market report include:
- ICON PLC
- Charles River Laboratories
- Syneos Health
- IQVIA Inc.
- GVK Biosciences Private Limited (Aragen)
- LabCorp
- Parexel International Corporation
- Thermo Fisher Scientific
- CTI Clinical Trial & Consulting
- PSI
- Medpace
- Ergomed
- WuXi AppTec
- Worldwide Clinical Trials
- Medidata Solutions, Inc
- Pharmaron GmbH
- SGS SA
- KCR SA
- Advanced Clinical Research Services, LLC
- Pharm-Olam, LLC (Allucent)
For more information about this report visit https://www.researchandmarkets.com/r/csso4t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251126425855/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900